pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

COMPANY OVERVIEW

Locus Biosciences is an emerging biotechnology company focused on the discovery and development of a next generation CRISPR-Cas platform for Programmed Cell Death.

LOCATION

  • Morrisville, NC, USA

    • THERAPEUTIC AREAS

  • Infectious Disease

    • WEBSITE

    https://www.locus-bio.com/

    CAREER WEBSITE

    https://www.locus-bio.com/careers/

    SOCIAL MEDIA

    INVESTORS

    abstract-ventures artis-ventures biosense tencent

    PRESS RELEASES


    Sep 13, 2022

    Locus Biosciences Announces First Patient Treated in the ELIMINATE Registrational Phase 2/3 Trial of LBP-EC01 for Urinary Tract Infections


    May 18, 2022

    Locus Biosciences Announces $35 Million Financing


    Oct 19, 2021

    Locus Biosciences Secures Financing of up to $25 Million from Hercules Capital


    Feb 24, 2021

    Locus Biosciences completes first-of-its-kind controlled clinical trial for CRISPR-enhanced bacteriophage therapy


    Feb 24, 2021

    Locus Biosciences completes first-of-its-kind controlled clinical trial for CRISPR-enhanced bacteriophage therapy


    For More Press Releases
    Google Analytics Alternative